Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-25

Clinical Trial Update: Daily Doxycycline for Early Syphillis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial sponsored by the University of Washington is evaluating daily doxycycline for early syphilis. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Doxycycline (Doxycycline)

Snippet

Sponsor: University of Washington | Conditions: Syphilis | Phase 2 | Status: RECRUITING